Peer-influenced content. Sources you trust. No registration required. This is HCN.

Essential Medical Reading

Your Weekly Roundup of the Most-Read News and Clinical References from Your Peers

Clinical Oncology News

Futibatinib Approved for Certain Patients with Advanced Intrahepatic Cholangiocarcinoma

Hepatology October 31st 2022

JAMA Network

Association of Prostate-Specific Antigen Screening Rates with Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities

Oncology, Medical October 31st 2022

Journal of Clinical Oncology

Sequencing of Androgen-Deprivation Therapy of Short Duration with Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials

Oncology, Medical October 31st 2022

Cancer Therapy Advisor

Poor Outcomes Seen in Advanced Cancer Patients Treated with Inpatient ICI Therapy

Hematology/Oncology October 31st 2022

Oncology News Central (ONC)

FDA Approves First Bispecific Antibody for Multiple Myeloma

Hematology/Oncology October 31st 2022

MedPage Today

Should We Still Be Concerned About Cell Phones and Brain Cancer?

Oncology, Medical October 31st 2022

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form